昼夜节律紊乱诱导小鼠骨关节炎:参与时钟和Bmal1失调和Pdgfa抑制。

IF 5.6 2区 医学 Q1 PHARMACOLOGY & PHARMACY
Ao Guo , Ke Zheng , Wanqi Jia , Shengting Zhang , Cong Sui
{"title":"昼夜节律紊乱诱导小鼠骨关节炎:参与时钟和Bmal1失调和Pdgfa抑制。","authors":"Ao Guo ,&nbsp;Ke Zheng ,&nbsp;Wanqi Jia ,&nbsp;Shengting Zhang ,&nbsp;Cong Sui","doi":"10.1016/j.bcp.2025.117342","DOIUrl":null,"url":null,"abstract":"<div><div>Circadian rhythm disturbance (CRD) is likely associated with impaired bone development and the development of osteoarthritis (OA). This study investigates the functions of circadian locomotor output cycles kaput (<em>Clock</em>) and brain and muscle Arnt-like 1 (<em>Bmal1</em>) in OA progression and explores the implicated molecular mechanisms. Mice were subjected to CRD for 70 d. This led to significant OA-like symptoms, accompanied by a reduction in the expression of <em>Clock</em> and <em>Bmal1</em>. Either <em>Clock</em> or <em>Bmal1</em> upregulation reduced serum concentrations of inflammatory cytokines (interleukin [IL]-1β and IL-6) in mice, and it reduced cartilage erosion and extracellular matrix degradation in their knee joints, with parallel findings observed in the isolated chondrocytes <em>in vitro</em>. The Clock:Bmal1 heterodimer binds to the enhancer upstream of the <em>Pdgfa</em> promoter to enhance its transcription. <em>Pdgfa</em> knockdown reversed the protective effects of <em>Clock</em> and <em>Bmal1</em> by inactivating the Pi3k/Akt and Erk1/2 cascade. By contrast, <em>Pdgfa</em> overexpression reduced chondrocyte damage, which was, however, negated by the Pi3k/Akt inhibitor LY294002. Collectively, this study validates that CRD is pertinent to the development of OA. Restoring <em>Clock</em> and <em>Bmal1</em> levels may help ameliorate chondrocyte loss in CRD-associated OA by activating <em>Pdgfa</em> transcription and enhancing Pi3k/Akt and Erk1/2 signaling pathways.</div></div>","PeriodicalId":8806,"journal":{"name":"Biochemical pharmacology","volume":"242 ","pages":"Article 117342"},"PeriodicalIF":5.6000,"publicationDate":"2025-09-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Circadian rhythm disturbance induces osteoarthritis in mice: Involvement of Clock and Bmal1 dysregulation and Pdgfa inhibition\",\"authors\":\"Ao Guo ,&nbsp;Ke Zheng ,&nbsp;Wanqi Jia ,&nbsp;Shengting Zhang ,&nbsp;Cong Sui\",\"doi\":\"10.1016/j.bcp.2025.117342\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><div>Circadian rhythm disturbance (CRD) is likely associated with impaired bone development and the development of osteoarthritis (OA). This study investigates the functions of circadian locomotor output cycles kaput (<em>Clock</em>) and brain and muscle Arnt-like 1 (<em>Bmal1</em>) in OA progression and explores the implicated molecular mechanisms. Mice were subjected to CRD for 70 d. This led to significant OA-like symptoms, accompanied by a reduction in the expression of <em>Clock</em> and <em>Bmal1</em>. Either <em>Clock</em> or <em>Bmal1</em> upregulation reduced serum concentrations of inflammatory cytokines (interleukin [IL]-1β and IL-6) in mice, and it reduced cartilage erosion and extracellular matrix degradation in their knee joints, with parallel findings observed in the isolated chondrocytes <em>in vitro</em>. The Clock:Bmal1 heterodimer binds to the enhancer upstream of the <em>Pdgfa</em> promoter to enhance its transcription. <em>Pdgfa</em> knockdown reversed the protective effects of <em>Clock</em> and <em>Bmal1</em> by inactivating the Pi3k/Akt and Erk1/2 cascade. By contrast, <em>Pdgfa</em> overexpression reduced chondrocyte damage, which was, however, negated by the Pi3k/Akt inhibitor LY294002. Collectively, this study validates that CRD is pertinent to the development of OA. Restoring <em>Clock</em> and <em>Bmal1</em> levels may help ameliorate chondrocyte loss in CRD-associated OA by activating <em>Pdgfa</em> transcription and enhancing Pi3k/Akt and Erk1/2 signaling pathways.</div></div>\",\"PeriodicalId\":8806,\"journal\":{\"name\":\"Biochemical pharmacology\",\"volume\":\"242 \",\"pages\":\"Article 117342\"},\"PeriodicalIF\":5.6000,\"publicationDate\":\"2025-09-17\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Biochemical pharmacology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0006295225006070\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"PHARMACOLOGY & PHARMACY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Biochemical pharmacology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0006295225006070","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

摘要

昼夜节律紊乱(CRD)可能与骨骼发育受损和骨关节炎(OA)的发展有关。本研究探讨了昼夜运动输出周期kaput (Clock)和脑肌类阿氏蛋白样1 (Bmal1)在骨性关节炎进展中的作用,并探讨了相关的分子机制。小鼠接受CRD治疗70 d,导致明显的oa样症状,并伴有Clock和Bmal1表达的降低。Clock或Bmal1上调均可降低小鼠血清中炎症细胞因子(白细胞介素[IL]-1β和IL-6)的浓度,并减少膝关节软骨侵蚀和细胞外基质降解,在体外分离的软骨细胞中也观察到类似的结果。时钟:Bmal1异二聚体与Pdgfa启动子上游的增强子结合以增强其转录。Pdgfa敲低通过灭活Pi3k/Akt和Erk1/2级联,逆转了Clock和Bmal1的保护作用。相比之下,Pdgfa过表达可减少软骨细胞损伤,而Pi3k/Akt抑制剂LY294002可消除这一作用。综上所述,本研究验证了CRD与OA的发展相关。通过激活Pdgfa转录和增强Pi3k/Akt和Erk1/2信号通路,恢复Clock和Bmal1水平可能有助于改善crd相关OA的软骨细胞损失。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

Circadian rhythm disturbance induces osteoarthritis in mice: Involvement of Clock and Bmal1 dysregulation and Pdgfa inhibition

Circadian rhythm disturbance induces osteoarthritis in mice: Involvement of Clock and Bmal1 dysregulation and Pdgfa inhibition
Circadian rhythm disturbance (CRD) is likely associated with impaired bone development and the development of osteoarthritis (OA). This study investigates the functions of circadian locomotor output cycles kaput (Clock) and brain and muscle Arnt-like 1 (Bmal1) in OA progression and explores the implicated molecular mechanisms. Mice were subjected to CRD for 70 d. This led to significant OA-like symptoms, accompanied by a reduction in the expression of Clock and Bmal1. Either Clock or Bmal1 upregulation reduced serum concentrations of inflammatory cytokines (interleukin [IL]-1β and IL-6) in mice, and it reduced cartilage erosion and extracellular matrix degradation in their knee joints, with parallel findings observed in the isolated chondrocytes in vitro. The Clock:Bmal1 heterodimer binds to the enhancer upstream of the Pdgfa promoter to enhance its transcription. Pdgfa knockdown reversed the protective effects of Clock and Bmal1 by inactivating the Pi3k/Akt and Erk1/2 cascade. By contrast, Pdgfa overexpression reduced chondrocyte damage, which was, however, negated by the Pi3k/Akt inhibitor LY294002. Collectively, this study validates that CRD is pertinent to the development of OA. Restoring Clock and Bmal1 levels may help ameliorate chondrocyte loss in CRD-associated OA by activating Pdgfa transcription and enhancing Pi3k/Akt and Erk1/2 signaling pathways.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Biochemical pharmacology
Biochemical pharmacology 医学-药学
CiteScore
10.30
自引率
1.70%
发文量
420
审稿时长
17 days
期刊介绍: Biochemical Pharmacology publishes original research findings, Commentaries and review articles related to the elucidation of cellular and tissue function(s) at the biochemical and molecular levels, the modification of cellular phenotype(s) by genetic, transcriptional/translational or drug/compound-induced modifications, as well as the pharmacodynamics and pharmacokinetics of xenobiotics and drugs, the latter including both small molecules and biologics. The journal''s target audience includes scientists engaged in the identification and study of the mechanisms of action of xenobiotics, biologics and drugs and in the drug discovery and development process. All areas of cellular biology and cellular, tissue/organ and whole animal pharmacology fall within the scope of the journal. Drug classes covered include anti-infectives, anti-inflammatory agents, chemotherapeutics, cardiovascular, endocrinological, immunological, metabolic, neurological and psychiatric drugs, as well as research on drug metabolism and kinetics. While medicinal chemistry is a topic of complimentary interest, manuscripts in this area must contain sufficient biological data to characterize pharmacologically the compounds reported. Submissions describing work focused predominately on chemical synthesis and molecular modeling will not be considered for review. While particular emphasis is placed on reporting the results of molecular and biochemical studies, research involving the use of tissue and animal models of human pathophysiology and toxicology is of interest to the extent that it helps define drug mechanisms of action, safety and efficacy.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信